Neurology - European Medical Journal

This site is intended for healthcare professionals

Continue

Neurology

Filter
EMJ
17 Oct 2016

AMPA Receptors ‘Wedged’ Closed by Epilepsy Drugs

EPILEPSY drugs designed to target glutamatergic AMPA receptors have been revealed to act as ‘wedges’, preventing dysregulated transmission of…
EMJ
12 Oct 2016

Paralysed Limb Movement Regained Following Stem Cell Injection

PARALYSIS may no longer be a permanent state for approximately 17,000 new spinal cord injury patients, following the successful experimental treatment of…
21 Sep 2016

Merck Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif® at the 2016 ECTRIMS Congress

Germany, September 12, 2016 – Merck, a leading science and technology company, today announced key symposia and more than 30 presentations of clinical…
EMJ
25 Jul 2016

Green Tea Used to Improve Cognitive Function of Individuals with Down’s Syndrome

INDIVIDUALS with Down’s syndrome have for the first time experienced an improvement in cognitive function as the result of receiving daily doses of green…
EMJ
25 Jul 2016

Stem Cells Offer Wider Potential After Restoring Motor Functions in Stroke Patients

THE SUCCESS of a small clinical trial using stem cells to restore the motor functions of stroke patients could have wider implications for the treatment…
19 Jul 2016

World Brain Day 2016 Devoted to the Ageing Brain

London, July 2016 – “It is becoming increasingly clear that neurological disorders, such as stroke and dementia but to name a few, are projected to rise…
10 Jun 2016

New Janssen Phase 3 Data in Patients with Moderately to Severely Active Rheumatoid Arthritis Shows Sirukumab Significantly Inhibited Radiographic Progression and Improves Signs and Symptoms of Disease

London, United Kingdom, 8 June, 2016 – Janssen Research & Development, LLC (Janssen) announced today results from a pivotal Phase 3 study evaluating…
EMJ
9 May 2016

‘Leaky’ Vessels Answer to Unresponsive Cancer

PROMISING research, which has implications for the development of treatments for medulloblastoma, the most common brain tumour in children, has emerged…
We’ve noticed you’re accessing
from North/South America.